David P Molkentine

6PUBLICATIONS
88CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Jan 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.

Marcelo V Negrao, Alvaro G Paula, David Molkentine

|Oct 11, 2023
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.

Phillip M Pifer, Liangpeng Yang, Manish Kumar

|Sep 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.

Natalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas

|Dec 30, 2021
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.

David P Molkentine, Jessica M Molkentine, Kathleen A Bridges

Pageof 1